Literature DB >> 17609176

The effect of population structure on the emergence of drug resistance during influenza pandemics.

Florence Débarre1, Sebastian Bonhoeffer, Roland R Regoes.   

Abstract

The spread of H5N1 avian influenza and the recent high numbers of confirmed human cases have raised international concern about the possibility of a new pandemic. Therefore, antiviral drugs are now being stockpiled to be used as a first line of defence. The large-scale use of antivirals will however exert a strong selection pressure on the virus, and may lead to the emergence of drug-resistant strains. A few mathematical models have been developed to assess the emergence of drug resistance during influenza pandemics. These models, however, neglected the spatial structure of large populations and the stochasticity of epidemic and demographic processes. To assess the impact of population structure and stochasticity, we modify and extend a previous model of influenza epidemics into a metapopulation model which takes into account the division of large populations into smaller units, and develop deterministic and stochastic versions of the model. We find that the dynamics in a fragmented population is less explosive, and, as a result, prophylaxis will prevent more infections and lead to fewer resistant cases in both the deterministic and stochastic model. While in the deterministic model the final level of resistance during treatment is not affected by fragmentation, in the stochastic model it is. Our results enable us to qualitatively extrapolate the prediction of deterministic, homogeneous-mixing models to more realistic scenarios.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609176      PMCID: PMC2394556          DOI: 10.1098/rsif.2007.1126

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  26 in total

1.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

2.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

4.  Resistance to anti-infective drugs and the threat to public health.

Authors:  David L Heymann
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

5.  (Meta)population dynamics of infectious diseases.

Authors:  B Grenfell; J Harwood
Journal:  Trends Ecol Evol       Date:  1997-10       Impact factor: 17.712

6.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

Review 7.  The treatment of influenza with antiviral drugs.

Authors:  Grant Stiver
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

8.  A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.

Authors:  Neil M Ferguson; Susan Mallett; Helen Jackson; Noel Roberts; Penelope Ward
Journal:  J Antimicrob Chemother       Date:  2003-03-13       Impact factor: 5.790

9.  Transmissibility of 1918 pandemic influenza.

Authors:  Christina E Mills; James M Robins; Marc Lipsitch
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

10.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

View more
  17 in total

1.  Management of drug resistance in the population: influenza as a case study.

Authors:  Seyed M Moghadas
Journal:  Proc Biol Sci       Date:  2008-05-22       Impact factor: 5.349

2.  Effects of influenza antivirals on individual and population immunity over many epidemic waves.

Authors:  K M Pepin; S Riley; B T Grenfell
Journal:  Epidemiol Infect       Date:  2012-03-30       Impact factor: 2.451

3.  Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J Theor Biol       Date:  2008-10-08       Impact factor: 2.691

4.  Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.

Authors:  Jennifer M Laplante; Steven A Marshall; Matthew Shudt; Tam T Van; Erik S Reisdorf; Lisa A Mingle; Peter A Shult; Kirsten St George
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

5.  Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol.

Authors:  Luis R Carrasco; Mark Jit; Mark I Chen; Vernon J Lee; George J Milne; Alex R Cook
Journal:  Emerg Themes Epidemiol       Date:  2013-05-07

6.  Amino acids transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011.

Authors:  Guang-Wu Chen; Kuo-Chien Tsao; Chung-Guei Huang; Yu-Nong Gong; Shih-Cheng Chang; Yi-Chun Liu; Hsiao-Han Wu; Shu-Li Yang; Tzou-Yien Lin; Yhu-Chering Huang; Shin-Ru Shih
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.

Authors:  Robert Moss; James M McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

8.  Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.

Authors:  Julien Arino; Christopher S Bowman; Seyed M Moghadas
Journal:  BMC Infect Dis       Date:  2009-01-22       Impact factor: 3.090

9.  Post-exposure prophylaxis during pandemic outbreaks.

Authors:  Seyed M Moghadas; Christopher S Bowman; Gergely Röst; David N Fisman; Jianhong Wu
Journal:  BMC Med       Date:  2009-12-02       Impact factor: 8.775

10.  The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.

Authors:  Benjamin M Althouse; Oscar Patterson-Lomba; Georg M Goerg; Laurent Hébert-Dufresne
Journal:  PLoS Comput Biol       Date:  2013-02-07       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.